{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-009270","form_type":"8-K","ticker":"MGTX","cik":"0001735438","company_name":"MeiraGTx Holdings plc","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.295476+00:00","generated_at":"2026-06-15T04:24:30.524421+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MeiraGTx Q1 net loss $30.4M; raises $60M PIPE; BLA on track for 2024","bullets":["Net loss $30.4M ($0.62/share) vs $31.0M ($0.70) in Q1 2022; cash $68.8M at March 31, 2023.","Raised ~$60M in May 2023 PIPE led by top holders Perceptive, Adage, Prosight, 683 Capital.","BLA submission for bota-vec (XLRP) remains on track for 2024; Phase 3 LUMEOS enrollment ongoing.","AAV-hAQP1 Phase 1 12-month data for xerostomia to be presented Q2 2023; Phase 2 to start Q2 2023.","License revenue $3.3M (down from $5.6M); R&D $22.3M (down from $23.1M); G&A $12.8M (up from $11.3M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-009270","json":"https://secwatch.observer/filing/0001558370-23-009270.json","markdown":"https://secwatch.observer/filing/0001558370-23-009270.md","text":"https://secwatch.observer/filing/0001558370-23-009270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023009270/0001558370-23-009270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023009270/mgtx-20230511x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T04:24:30.524421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f76d7e6adf94539e8b2c110a7fc1973e5021e434","claim":"MeiraGTx Holdings plc reported the quarter ended March 31, 2023 results: revenue $3.3 million.","evidence_excerpt":"of 20 25 . ​ Financial Results ​ Cash and cash equivalents were $68.8 million as of March 31, 2023, compared to $115.5 million as of December 31, 2022. ​ License revenue was $ 3.3 million for the quarter ended March 31, 2023, compared to $5.6 million for the quarter ended March 31, 2","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023009270/0001558370-23-009270-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$3.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}